tradingkey.logo

Garuda Therapeutics Closes $50 Million Series A-1 Financing To Advance Off-The-Shelf Blood Stem Cell Therapies

ReutersMar 4, 2025 1:42 PM

- Kyowa Kirin Co Ltd 4151.T:

  • GARUDA THERAPEUTICS CLOSES $50 MILLION SERIES A-1 FINANCING TO ADVANCE OFF-THE-SHELF BLOOD STEM CELL THERAPIES

  • GARUDA: INVESTORS INCLUDED ORBIMED, NORTHPOND VENTURES AND CORMORANT ASSET MANAGEMENT, WITH NEW STRATEGIC INVESTMENT FROM KYOWA KIRIN CO., LTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI